Previous Close | 8.65 |
Open | 9.11 |
Bid | 12.25 x 900 |
Ask | 15.33 x 1800 |
Day's Range | 8.85 - 12.46 |
52 Week Range | 5.66 - 12.47 |
Volume | |
Avg. Volume | 2,095,201 |
Market Cap | 919.042M |
Beta (5Y Monthly) | 0.49 |
PE Ratio (TTM) | 58.49 |
EPS (TTM) | 0.21 |
Earnings Date | Mar 02, 2022 - Mar 07, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 16, 2022 |
1y Target Est | N/A |
NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: SIGA Technologies (NASDAQ: SIGA), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), GeoVax Labs (NASDAQ: GOVX), and PharmaDrug (OTC: LMLLF) (CSE: PHRX). As the global pharma market suprasses $1.3 trillion dollars (Statista), emerging technologies and healthcare research innovations are unleashing new exponential
The outbreak still consists of fewer than a hundred cases, according to the World Health Organization.
Emergent BioSolutions, Chimerix and SIGA Technologies have been included in this Analyst Blog.